XPR – Lifestyle Demo
Author:
argenx SE
argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
April 30, 2026
argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP
April 18, 2026
argenx announces Annual General Meeting of Shareholders on May 6, 2026
March 20, 2026